Latest Clinical research Stories
-- Trial Met Primary Efficacy Endpoint with Statistical Significance After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Eisai Inc.
Each week FDAnews reporters spend hours talking to the quality managers at recently inspected facilities, surveying them about what happened during the inspection and what caught them by surprise.
Conference Call Scheduled for Monday, November 3, 2014 at 10:00 a.m. Eastern time JERUSALEM, October 31, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc.
SAN DIEGO, Oct. 31, 2014 /PRNewswire/ -- Mast Therapeutics, Inc.
FDA states that approval will not be final until Astagraf XL® exclusivity expires; Veloxis is appealing this decision HORSHOLM, Denmark, Oct.
NEW YORK, Oct. 31, 2014 /PRNewswire/ -- Analyst Brief by Small Cap Traders. Tenax Therapeutics, Inc.
DMG Productions explores the latest breakthroughs in health and medicine. Zug, Switzerland (PRWEB) October 30, 2014 PSI CRO (PSI) announced that they
DrugDev is sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November.
LEXINGTON, Mass., Oct.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.